MedPath

TEGLUTIK 5MG/ML SUSPENSION ORAL

TEGLUTIK 5MG/ML SUSPENSION ORAL

Commercialized
Register Number

78243

Prescription Type

Uso Hospitalario

Authorization Date

Feb 6, 2014

Dosage Form

SUSPENSIÓN ORAL

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number78243
EMA Approved
No

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

RILUZOLActive
Quantity: 0,5 g
Name: RILUZOL

ATC CLASSIFICATION (3)

N07X
N07XX
N07XX02

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.